Nos1-CreERT2
Nomenclature
C57BL/6Smoc-Nos1em1(CreERT2-SV40polyA)Smoc
Cat. NO.
NM-KI-200091
Strain State
Sperm cryopreservation
Gene Summary
Gene Symbol
Nos1
Model Description
Validation Data

Fig. 1 CreERT2-mediated recombination in the brian of Nos1CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the NOS1 positive neurons of Nos1CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 2 CreERT2-mediated recombination in the large intestine of Nos1CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the muscular layer of the wall of the large intestine derived from Nos1CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 3 CreERT2-mediated recombination in the small intestine of Nos1CreERT2 /+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the muscular layer of the wall of the small intestine derived from Nos1CreERT2 /+; Rosa26tdTomato/+ mouse after tamoxifen treatment.

Fig. 4 Detection of tdTomato(red) in various tissues of Nos1CreERT2/+; Rosa26tdTomato/+ mice. CreERT2 mediated recombination can be detected in some cells of the brain and intestine. Some leakiness were detected prior to tamoxifen exposure. Besides, tamoxifen-dependent cre recombinase expression can also be detected in some cells derived from eyes, lung, submandibular gland, kidney, spleen, thymus, muscle and ovary, except for heart, brown fat tissue and liver. (For more detailed information please contact our technical advisor.)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more